Literature DB >> 16352453

Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.

J Martijn Bos1, Rainer N Poley, Melissa Ny, David J Tester, Xiaolei Xu, Matteo Vatta, Jeffrey A Towbin, Bernard J Gersh, Steve R Ommen, Michael J Ackerman.   

Abstract

BACKGROUND: TTN-encoded titin, CSRP3-encoded muscle LIM protein, and TCAP-encoded telethonin are Z-disc proteins essential for the structural organization of the cardiac sarcomere and the cardiomyocyte's stretch sensor. All three genes have been established as cardiomyopathy-associated genes for both dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). Here, we sought to characterize the frequency, spectrum, and phenotype associated with HCM-associated mutations in these three genes in a large cohort of unrelated patients evaluated at a single tertiary outpatient center.
METHODS: DNA was obtained from 389 patients with HCM (215 male, left ventricular wall thickness of 21.6+/-6 mm) and analyzed for mutations involving all translated exons of CSRP3 and TCAP and targeted HCM-associated exons (2, 3, 4, and 14) of TTN using polymerase chain reaction (PCR), denaturing high performance liquid chromatography (DHPLC), and direct DNA sequencing. Clinical data were extracted from patient records and maintained independent of the genotype.
RESULTS: Overall, 16 patients (4.1%) harbored a Z-disc mutation: 12 had a MLP mutation and 4 patients a TCAP mutation. No TTN mutations were detected. Seven patients were also found to have a concomitant myofilament mutation. Seven patients with a MLP-mutation were found to harbor the DCM-associated, functionally characterized W4R mutation. W4R-MLP was also noted in a single white control subject. Patients with MLP/TCAP-associated HCM clinically mimicked myofilament-HCM.
CONCLUSIONS: Approximately 4.1% of unrelated patients had HCM-associated MLP or TCAP mutations. MLP/TCAP-HCM phenotypically mirrors myofilament-HCM and is more severe than the subset of patients who still remain without a disease-causing mutation. The precise role of W4R-MLP in the pathogenesis of either DCM or HCM warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352453      PMCID: PMC2756511          DOI: 10.1016/j.ymgme.2005.10.008

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  35 in total

1.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure.

Authors:  S Arber; J J Hunter; J Ross; M Hongo; G Sansig; J Borg; J C Perriard; K R Chien; P Caroni
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

3.  Mapping of a human LIM protein (CLP) to human chromosome 11p15.1 by fluorescence in situ hybridization.

Authors:  Y W Fung; R X Wang; H H Heng; C C Liew
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

4.  Titins: giant proteins in charge of muscle ultrastructure and elasticity.

Authors:  S Labeit; B Kolmerer
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

5.  Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.

Authors:  K Poetter; H Jiang; S Hassanzadeh; S R Master; A Chang; M C Dalakas; I Rayment; J R Sellers; L Fananapazir; N D Epstein
Journal:  Nat Genet       Date:  1996-05       Impact factor: 38.330

6.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.

Authors:  A Kimura; H Harada; J E Park; H Nishi; M Satoh; M Takahashi; S Hiroi; T Sasaoka; N Ohbuchi; T Nakamura; T Koyanagi; T H Hwang; J A Choo; K S Chung; A Hasegawa; R Nagai; O Okazaki; H Nakamura; M Matsuzaki; T Sakamoto; H Toshima; Y Koga; T Imaizumi; T Sasazuki
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

7.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults.

Authors:  B J Maron; J M Gardin; J M Flack; S S Gidding; T T Kurosaki; D E Bild
Journal:  Circulation       Date:  1995-08-15       Impact factor: 29.690

8.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

9.  Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Michele A Jaeger; Steve R Ommen; Melissa L Will; Bernard J Gersh; A Jamil Tajik; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-08-04       Impact factor: 24.094

10.  Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.

Authors:  H Watkins; D Conner; L Thierfelder; J A Jarcho; C MacRae; W J McKenna; B J Maron; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  68 in total

Review 1.  Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors:  Ray E Hershberger
Journal:  J Cardiovasc Transl Res       Date:  2008-05-20       Impact factor: 4.132

Review 2.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

3.  Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands.

Authors:  I Christiaans; E A Nannenberg; D Dooijes; R J E Jongbloed; M Michels; P G Postema; D Majoor-Krakauer; A van den Wijngaard; M M A M Mannens; J P van Tintelen; I M van Langen; A A M Wilde
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

4.  Depletion of zebrafish titin reduces cardiac contractility by disrupting the assembly of Z-discs and A-bands.

Authors:  Michael Seeley; Wei Huang; Zhenyue Chen; William Oscar Wolff; Xueying Lin; Xiaolei Xu
Journal:  Circ Res       Date:  2006-12-14       Impact factor: 17.367

5.  Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors:  Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal:  Biophys J       Date:  2011-02-16       Impact factor: 4.033

6.  Sarcomere-based genetic enhancement of systolic cardiac function in a murine model of dilated cardiomyopathy.

Authors:  Jiayang Li; Kenneth S Gresham; Ranganath Mamidi; Chang Yoon Doh; Xiaoping Wan; Isabelle Deschenes; Julian E Stelzer
Journal:  Int J Cardiol       Date:  2018-09-21       Impact factor: 4.164

7.  Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors:  I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

8.  Human muscle LIM protein dimerizes along the actin cytoskeleton and cross-links actin filaments.

Authors:  Céline Hoffmann; Flora Moreau; Michèle Moes; Carole Luthold; Monika Dieterle; Emeline Goretti; Katrin Neumann; André Steinmetz; Clément Thomas
Journal:  Mol Cell Biol       Date:  2014-06-16       Impact factor: 4.272

9.  Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization.

Authors:  Mohammad M Ghahramani Seno; Capucine Trollet; Takis Athanasopoulos; Ian R Graham; Pingzhao Hu; George Dickson
Journal:  BMC Genomics       Date:  2010-06-01       Impact factor: 3.969

10.  Dynamic strength of titin's Z-disk end.

Authors:  Veronika Kollár; Dávid Szatmári; László Grama; Miklós S Z Kellermayer
Journal:  J Biomed Biotechnol       Date:  2010-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.